bluebird bio, Inc. (BLUE) News
Filter BLUE News Items
BLUE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BLUE News Highlights
- For BLUE, its 30 day story count is now at 17.
- Over the past 19 days, the trend for BLUE's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about BLUE are BIO, AMP and LI.
Latest BLUE News From Around the Web
Below are the latest news stories about BLUEBIRD BIO INC that investors may wish to consider to help them evaluate BLUE as an investment opportunity.
Should You Invest in Bluebird Bio Right Now?After two December share price crashes, there's no evident cure for Bluebird Bio's ills. |
If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have TodayCan things get better for this struggling stock? |
1 Green Flag and 1 Red Flag for Bluebird Bio StockThe stock has been in the news lately. |
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024Doing a little math and doing a little extra research can make a big difference. |
Bluebird Bio Stock Is in Free Fall Weeks After a Landmark FDA Approval. Here’s Why.The plummeting share price is a potent symbol of the structural problems still facing small and midsize biotechs. |
bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common StockSOMERVILLE, Mass., December 20, 2023--bluebird bio, Inc. (Nasdaq: BLUE) ("bluebird") today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price of $1.50 per share, before deducting underwriting discounts and commissions. bluebird also granted the underwriters a 30-day option to purchase up to an additional 12,499,999 shares of its common stock at the public offering price per share, less underwriting discounts and commissio |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning! |
bluebird bio, Inc. Announces Proposed Public Offering of Common StockSOMERVILLE, Mass., December 18, 2023--bluebird bio, Inc. (Nasdaq: BLUE) ("bluebird") today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock. bluebird also intends to grant the underwriters a 30-day option to purchase up to an additional $22,500,000 of shares of its common stock to be sold in the offering. The offering, actual size and terms are subject to market conditions, and there can be no assurance as to whether or when the offeri |
Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock?An expected big win is rapidly turning into a defeat. |
3 Gene-Editing Stocks With the Potential to Mint MillionairesGene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR. |